Precision Diagnostics conducted its first Continuing Medical Education (CME) session with the committed General Practitioners at Royal Prima Hospital, led by our CEO, Dr. Rebecca Tay, and COO, Dr. Gew Soon Peng. The session focused on the practical application of Pharmacogenomics (PGx) and Nutrigenomics (NGx) in improving clinical decision-making and patient outcomes, inclusive of SKP (Satuan Kredit Profesi).

The discussion highlighted how genetic variability influences medication efficacy, metabolism, and the risk of adverse reactions, reinforcing the value of integrating genomics into everyday prescribing protocols.

Key clinical takeaways included:

• Implementing accurate prescribing guildelines from the start, leading to safer and more effective treatments.
• Making confident dosing decisions supported by precise, patient-specific genetic information.
• Optimising therapeutic outcomes across various specialties, including cardiology, psychiatry, and pain management.

The session also featured the sharing of updated insights and real-world case applications, contributing to more informed, personalised patient care. We are deeply appreciative of Royal Prima Hospital for their continued collaboration, and of the participating GPs for their commitment to advancing precision-based practice.